These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1127083)

  • 1. Altered tissue response to glucagon in obesity.
    Schade DS; Eaton RP
    J Clin Endocrinol Metab; 1975 Apr; 40(4):732-5. PubMed ID: 1127083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Metabolic effect of glucagon in obese individuals. II. Effect on the levels of nonesterified fatty acids and beta-hydroxybutyric acid in the blood].
    Beno I; Chorváthová V; Jurcovicová M
    Cas Lek Cesk; 1983 Nov; 122(44):1360-3. PubMed ID: 6640603
    [No Abstract]   [Full Text] [Related]  

  • 3. Modulation of the catabolic activity of glucagon by endogenous insulin secretion in obese man.
    Schade DS; Eaton PR
    Acta Diabetol Lat; 1977; 14(1-2):62-72. PubMed ID: 596102
    [No Abstract]   [Full Text] [Related]  

  • 4. The contribution of endogenous insulin secretion to the ketogenic response to glucagon in man.
    Schade DS; Eaton RP
    Diabetologia; 1975 Dec; 11(6):555-9. PubMed ID: 1205024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of obesity on ambient plasma glucose, free fatty acid, insulin, growth hormone, and glucagon concentrations.
    Golay A; Swislocki AL; Chen YD; Jaspan JB; Reaven GM
    J Clin Endocrinol Metab; 1986 Aug; 63(2):481-4. PubMed ID: 3522620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of fatty acid metabolism by glucagon in man. II. Effects in insulin-deficient diabetics.
    Schade DS; Eaton RP
    Diabetes; 1975 May; 24(5):510-5. PubMed ID: 805077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucagon regulation of plasma ketone body concentration in human diabetes.
    Schade DS; Eaton RP
    J Clin Invest; 1975 Nov; 56(5):1340-4. PubMed ID: 1184755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative effects of glucagon injection in normal-weight and obese nondiabetic subjects. Preliminary report].
    Scornavachi JC; Vague P; Rouvier-Leroy C
    Diabete; 1968; 16(2):126-31. PubMed ID: 4923394
    [No Abstract]   [Full Text] [Related]  

  • 9. Insulin and glucagon responses to adrenaline infusion in abdominal obese men.
    Mauriège P; Klein Kranenbarg WM; Prud'homme D; Lamarche B; Tremblay A; Bouchard C; Nadeau A; Després JP
    Int J Obes Relat Metab Disord; 1996 Jul; 20(7):668-76. PubMed ID: 8817361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of acetylsalicylic acid on plasma glucose, free fatty acid, betahydroxybutyrate, glucagon and C-peptide responses to salbutamol in insulin-dependent diabetic subjects.
    Giugliano D; Passariello N; Torella R; Cerciello T; Varricchio M; Sgambato S
    Acta Diabetol Lat; 1981; 18(1):27-36. PubMed ID: 7211088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of short term physiological elevations of plasma glucagon concentration on plasma triglyceride concentration in normal and diabetic man.
    Schade DS; Eaton RP
    Horm Metab Res; 1977 Jul; 9(4):253-7. PubMed ID: 892688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of exogenous glucagon on the concentrations of free fatty acids, glucose and immunoreactive insulin during dynamic exercise and restitution in healthy subjects.
    Markiewicz K; Cholewa M; Górski L
    Acta Physiol Pol; 1979; 30(4):427-35. PubMed ID: 506749
    [No Abstract]   [Full Text] [Related]  

  • 13. Acipimox potentiates growth hormone (GH) response to GH-releasing hormone with or without pyridostigmine by lowering serum free fatty acid in normal and obese subjects.
    Lee EJ; Nam SY; Kim KR; Lee HC; Cho JH; Nam MS; Song YD; Lim SK; Huh KB
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2495-8. PubMed ID: 7629249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic changes following sibutramine-assisted weight loss in obese individuals: role of plasma free fatty acids in the insulin resistance of obesity.
    McLaughlin T; Abbasi F; Lamendola C; Kim HS; Reaven GM
    Metabolism; 2001 Jul; 50(7):819-24. PubMed ID: 11436188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of insulin treatment on the metabolic response to glucagon in diabetes.
    Elkeles RS; Hambley J; Frost PG
    Diabete Metab; 1977 Mar; 3(1):35-8. PubMed ID: 192610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic effects of glucagon in endogenous hypertriglyceridemia.
    Nosadini R; Soldà G; de Biasi F; Tiengo A
    Acta Diabetol Lat; 1978; 15(5-6):251-8. PubMed ID: 219650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of fatty acid metabolism by glucagon in man. I. Effects in normal subjects.
    Schade DS; Eaton RP
    Diabetes; 1975 May; 24(5):502-9. PubMed ID: 1126591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ketogenic action of glucagon in insulin-dependent diabetic subjects.
    Harano Y; Ohgaku S; Shimizu Y; Izumi K; Takahashi J
    Endocrinol Jpn; 1977 Apr; 24(2):121-8. PubMed ID: 406133
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of glucagon on the serum levels of free fatty acids and glycerol in children].
    Spahn U; Jablońska-Ulbrych A
    Z Kinderheilkd; 1969; 106(3):213-24. PubMed ID: 5797236
    [No Abstract]   [Full Text] [Related]  

  • 20. Restoration of growth hormone (GH) response to GH-releasing hormone in elderly and obese subjects by acute pharmacological reduction of plasma free fatty acids.
    Pontiroli AE; Manzoni MF; Malighetti ME; Lanzi R
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3998-4001. PubMed ID: 8923850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.